Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy.
Journal Information
Full Title: Nucl Med Commun
Abbreviation: Nucl Med Commun
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nuclear Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest H.P. has attended and received honoraria for advisory boards, travel expenses to medical meetings and served as a consultant for Blue Earth Diagnostics Ltd, AstraZeneca, Astellas, Janssen, Sanofi Aventis, Ferring, Bayer and Novartis. D.B. has acted as a speaker for and received travel support from Blue Earth Diagnostics Ltd. E.J.T. is currently an employee of Blue Earth Diagnostics Ltd. J.B. and A.F.S. have no relevant conflicts to disclose. The FALCON Study was sponsored by Blue Earth Diagnostics Ltd with a grant from Innovate UK."
"Editorial Support was provided by Dr Catriona Turnbull (Blue Earth Diagnostics Ltd). Editorial Support was provided by Dr Catriona Turnbull (Blue Earth Diagnostics Ltd)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025